<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02348229</url>
  </required_header>
  <id_info>
    <org_study_id>2013-212</org_study_id>
    <nct_id>NCT02348229</nct_id>
  </id_info>
  <brief_title>Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins</brief_title>
  <acronym>ERASAG</acronym>
  <official_title>Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins in Patients With Advanced Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators designed a prospective randomized, controlled clinical trial then recruited
      149 consecutive advanced gastric cancer patients. Further divided into a ERAS group (n=73)
      and a conventional pathway group (n=76). Surgical technique in both groups was same
      laparoscopic-assisted gastrectomy with D2 lymphadenectomy. Compared outcomes included
      clinical parameters and serum indicators.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enhanced recovery after surgery combined with laparoscopic-assisted gastrectomy was
      successfully carried out in this study. Recovery parameters such as the length of time to
      return to normal diet,mean hospital stay (d) were recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compartition of postoperative hospital stay</measure>
    <time_frame>up to 30 days after the operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in C-Reactive Protein( CRP) and visceral proteins level</measure>
    <time_frame>baseline and 5 days</time_frame>
    <description>1day before and 1-5days after operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">149</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>ERAS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ERAS protocols</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional pathway group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>using conventional pathway</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>Normal meal allowed until 6 h before surgery and Carbohydrate drink until 2 h before surgery</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>No bowel preparation</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>No nasogastric placement; if used, remove on the 1st postoperative day</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>Vasoactive drugs used if need be</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>Temperature management</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>Intra-abdominal drains not to be used</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>Intraperitoneal Ropivicaine infusion</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>On the 1st postoperative day Nasogastric catheter removed /Urinary catheter removed.
Oral non‐opioid analgesia/Drinking 0.5L liquid. Active mobilisation</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>On the 2nd postoperative day：Drains removed Oral diet was initiated</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>3-4th postoperative day： Stop oral non opioid analgesia</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols</intervention_name>
    <description>On the5-6th postoperative day Check discharge criteria</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>No solid foods at dinner before surgery and no liquids 12 h before surgery. Routine bowel preparation Nasogastric placement on the morning of surgery</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>Routine use of anesthesia medicine. Standard 5-trocar laparoscopy-assisted procedure. I.V. fluids not restricted (Ringer's lactate 20 ml/kg in the first hour, then at the rate of 10-12 ml/kg/h) Routine use of abdominal drainage tubes and placement of catheters.</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>1st postoperative day: Keep Nasogastric catheter Removal of urinary catheter Opioid analgesic by intramuscular injection Parenteral nutrition until flatus. I.V. fluids not restricted Mobilization in bed</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>2nd postoperative day Patient is advised to get out of bed until 24-48h after surgery</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>3-4th postoperative day： Remove nasogastric tube after flatus Oral liquids started. Encouraged to walk in the ward.</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional pathway group</intervention_name>
    <description>5-6th postoperative day：Oral diet was changed from liquids to semi-fluids and normal food.
Drains removed</description>
    <arm_group_label>conventional pathway group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-75 years old

          2. Diagnosis confirmed by the endoscopic biopsy and total-body CT scan

          3. No history of the chronic renal disease ,chronic liver disease, cardiopulmonary
             dysfunction, ASA score≦3

          4. No neoadjuvant chemotherapy and radiotherapy

          5. No digestive obstruction and distant metastasis

        Exclusion Criteria:

          1. Conversion to open gastrectomy

          2. A large amount of bleeding leading(＞500ml)

          3. Patients withdrew their consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quan Wang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2015</study_first_submitted>
  <study_first_submitted_qc>January 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <last_update_submitted>January 27, 2015</last_update_submitted>
  <last_update_submitted_qc>January 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Enhanced recovery after surgery</keyword>
  <keyword>laparoscopic gastrectomy</keyword>
  <keyword>advanced gastric cancer</keyword>
  <keyword>C-reactive,visceral proteins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

